✦ LIBER ✦

AM3 (InmunoferÃ³nÂ®) as an adjuvant to hepatitis B vaccination in hemodialysis patients

✍ Scribed by PÃ©rez-GarcÃa, Rafael; PÃ©rez-GarcÃa, Alfonso; Verbeelen, Dierik; Bernstein, Erica D.; Villarrubia, Vicente G.; Ãlvarez-Mon, Melchor

Book ID: 104474460
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 157 KB
Volume: 61
Category: Article
ISSN: 0085-2538
DOI: 10.1046/j.1523-1755.2002.00335.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant γ-interferon as adjuvant to

Recombinant γ-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients

✍ Juan Antonio Quiroga; Inmaculada Castillo; Juan Carlos Porres; Santos Casado; Fe 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

Peripheral blood dendritic cells and GM-

Peripheral blood dendritic cells and GM-CSF as an adjuvantfor hepatitis B vaccination in hemodialysis patients

✍ VERKADE, MARTIJN A; VAN DE WETERING, JACQUELINE; KLEPPER, MARISKA; VAESSEN, LEON 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Interferon as an adjuvant for hepatitis

Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations

✍ Grob, P. J. ;Joller-Jemelka, H. I. ;Binswanger, U. ;Zaruba, K. ;Descoeudres, C. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 292 KB

The risk of hepatitis B transmission fro

The risk of hepatitis B transmission from staff to patients in hemodialysis units–-an overrated problem?

✍ Douglas R. LaBrecque; Arun K. Dhand 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

The staff and patients in hemodialysis units have the greatest hospital risk of acquiring hepatitis B (HB) infection. We followed the patients of two dialysis nurses in two different dialysis units. One nurse dialyzed 19 patients a total of 50 times during the prodrome of acute HB. The second nurse

Delayed redistribution of CD27, CD40 and

Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation

✍ Mitsufumi Nishio; Katsuya Fujimoto; Satoshi Yamamoto; Tomoyuki Endo; Toshiya Sak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB